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Honeybees use a variety of defence mechanisms to reduce
disease infection and spread throughout the colony. Many
of these defences rely on the collective action of multiple
individuals to prevent, reduce or eradicate pathogens—often
referred to as ‘social immunity’. Glucose oxidase (GOX) and
some antimicrobial peptides (e.g. defensin-1 or Def1) are
secreted by the hypopharyngeal gland of adult bees on larval
food for their antiseptic properties. Because workers secrete
these compounds to protect larvae, they have been used as
‘biomarkers’ for social immunity. The aim of this study was
to investigate if GOX and Def1 are induced after pathogen
exposure to determine whether its production by workers is
the result of a collective effort to protect the brood and colony
in response to a pathogen challenge. Specifically, we quantified
GOX and Def1 in honeybee adults before and after colony-level
bacterial infection by American foulbrood ((AFB), Paenibacillus
larvae). Overall, our results indicate that levels of GOX and
Def1 are not induced in response to pathogenic infections. We
therefore conclude that GOX and Def1 are highly constitutive
2017 The Authors. Published by the Royal Society under the terms of the Creative Commons
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and co-opted as mechanisms of social immunity, and these factors should be considered when
investigating immunity at the individual and colony level in social insects.
1. Introduction
Social species rely on individual and group mechanisms to reduce the increased risk of disease
transmission that results from living in large colonies [1,2]. When defence mechanisms rely on collective
actions to prevent, reduce or eradicate diseases, they are referred to as ‘social immunity’ [1,3]. The
honeybee (Apis mellifera) is a model organism to study the role of physiological and behavioural
mechanisms on social immunity [4,5]. These defence mechanisms can result from individual or group
defences and range on a spectrum from highly constitutive (regularly expressed as a first line of
defence) to highly inducible (upregulated in response to exposure) (figure 1; [6]). For example, common
inducible group behavioural defences of social immunity include allogrooming [7] and hygienic
behaviours—defined as the ability of workers to remove diseased brood from the nest [8], while
worker task allocation is highly constitutive [9]. In terms of individual physiological immunity, the
phenoloxidase cascade is often described as a model for constitutive innate immunity [10,11], while
antimicrobial peptides are highlighted as highly inducible, even though they show some constitutive
expression [4].
One set of mechanisms of social immunity is based on the use of antimicrobial compounds to
reduce the probability of pathogens entering the nest or spreading among individuals [12]. These
antimicrobial compounds can be environmentally collected or self-produced. Honeybees collect plant
resins to modify their nesting environments by inhibiting microbial growth with these externally
gathered compounds [13–15]. In this case, collection of plant-produced resources is both constitutively
expressed [14,16,17] and induced by pathogen exposure [18,19]. On the other hand, antimicrobial
compounds produced by individuals can be externally secreted for group and food sanitation
[20], as are venom gland products that are antiseptic and often found on cuticles and brood
cells [21–23].
Two other self-produced compounds that are often considered biomarkers of social immunity—
because of their roles in sanitizing honey stores and brood food—are glucose oxidase (GOX) and
defensin-1 (Def1) [20,24,25]. GOX is an enzyme produced by the hypopharyngeal glands that converts
β-D-glucose into D-gluconic acid and hydrogen peroxide (H2O2) through an oxidation reaction [26]. The
antiseptic properties of H2O2 can prevent bacterial and fungal growth [26,27]. Even though levels of
H2O2 production are positively correlated with the inhibition of pathogen development in larval food of
honeybees (e.g. honey [28] and royal jelly [27]), it is unknown whether this antimicrobial secretion can
be induced as a response to pathogen pressure. Def1 is an antimicrobial peptide, and unlike its other
isoform defensin-2, it is also produced mainly by the hypopharyngeal glands of honeybees and found
in the royal jelly fed to developing larvae [24].
In this study, we investigate whether GOX activity and Def1 expression are activated in nurse bees
after a colony-level challenge with the causative agent of the bacterial brood disease American foulbrood
((AFB), Paenibacillus larvae). Specifically, we quantified levels of enzymatic activity of GOX and gene
expression of GOX and Def1 for nurse bees in healthy and AFB-infected honeybee colonies to test
whether or not these compounds are induced in nurse bees after colony-level exposure to pathogens.
Honeybee larvae become infected with AFB by the transfer of spores via contaminated food, which
come from spores left behind in re-used cells or from adult bees carrying them and then contaminating
brood food [29]. Therefore, one hypothesis is that GOX and Def1 production is inducible in nurse bees
because these compounds either; (i) directly increase in nurse bees owing to exposure to AFB spores
leading to increased brood food sanitation and decontamination of the hive, or (ii) nurse bee physiology
changes in response to the presence of infected larvae suggesting that these antimicrobial compounds
are produced because nest-mates (larvae in this case) are sick. This change in physiology after nest-mate
infection has recently been documented in queens [30]. The alternative hypothesis is that GOX and Def1
production are not inducible in either manner, meaning they are constitutively expressed and are co-
opted as a social immune defence. Our results shed insights into the role of GOX and Def1 in the larger












































Figure 1. Framework for expression of social and individual immune traits ranging from highly constitutive to highly inducible. Social
insects function, in many ways, as a ‘superorganism’. Both the social and individual immune systems havemany analogous features and
therefore language established for physiological immunity (constitutive versus inducible immunity) can be extended to the discussion of
social immunity (see the electronic supplementary material, appendix 1 for more information on rationale and full citations for position
of traits).
2. Material and methods
2.1. Experiment
We performed the experiment in Raleigh, NC, USA, using five frame nucleus colonies of A. mellifera for
eight experimental colonies (five for AFB treatment and three controls), each containing three brood
frames and one honey frame, a laying queen and equally sized adult bee populations. The queen
of one of the control colonies died during the first week of the experiment, we therefore used two
colonies as controls, and five colonies for the bacterial treatment using the AFB solution. Hives were
located in an isolated area to prevent transmission of P. larvae–a.k.a. AFB–to healthy colonies. For
bacterial infection treatment, we collected ca 30 AFB ‘scales’ or the dried remnants of symptomatic,
dead larvae from an infected colony in Mocksville, NC, USA that was obtained from the North Carolina
Department of Agriculture. Following standard protocols, scales were macerated with sterile deionized
water, heat-shocked for 10 min at 80°C, and diluted in a 10% sucrose solution at a final concentration
of 1.5× 107 spores ml−1. Three control colonies just received the sucrose solution. To infect the five
treatment colonies, bees were shaken off each frame and combs were sprayed with a 5 ml solution on
each side (following recipe in [31]). Before infection, we marked 100 newly emerged bees with coloured
paint to identify age of bees. Fifteen age-marked individuals were collected at 7 and 14 days old before
infection, and stored at −80°C. We inoculated treatment colonies with AFB during week 3, following the
T0 14 day old bee collection, and re-inoculated on week 4 (table 1). We repeated the infection procedure to
guarantee that colonies would show AFB symptoms. The same marking and sampling procedures were
repeated to collect 7 and 14 day old bees twice after infection (T1 and T2). AFB infections were quantified
weekly throughout the experiment by counting the total number of symptomatic cells in the three brood
frames for each colony.
2.2. Glucose oxidase enzymatic activity
We quantified the enzymatic activity of GOX from heads of 12 individuals per colony for each treatment
and time period in our experiment. Head tissue was homogenized on ice in phosphate buffered
saline (pH 7.4) using pestles. To quantify GOX activity, we used a peroxidase assay kit (ThermoFisher
A22188) that produces the red compound resorufin with the presence of hydrogen peroxide (H2O2).




Table 1. Summary of disease infection in experimental colonies through time. (Infectionwas quantified as the number of cells containing
dead, symptomatic larvae or AFB ‘scale’ in colonies after initial infection.)
week 1 week 2 week 3 week 4 week 5 week 6 week 7
AFB 1 0 0 0 0 26 91 228
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AFB 2 0 0 0 5 67 89 71
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AFB 3 0 0 0 3 6 178 30
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AFB 4 0 0 0 1 58 57 125
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AFB 5 0 0 0 15 143 342 a
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
control 1 0 0 0 0 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
control 3 0 0 0 0 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
bee marking T0 T 1 T2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
collection 7 d (T0) 14 d (T0) 7d (T1) 14d (T1) 7d (T2) 14d (T2)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
treatment AFB AFB
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aColony AFB 5 absconded before week 7.
was estimated as the maximum velocity (Vmax) of the rate of production of the red compound at an
absorbance of 560 nm for 60 min. Vmax was calculated as the slope of the linear phase of the reactions
using the software KCJUNIOR v. 1.22 (Bio-Tek, Winooski, VT, USA). Each reaction was repeated three
times to estimate errors associated with sample preparation.
2.3. Gene expression
We quantified gene expression of GOX (F: GAG GGC GGA AAA TCA TCA GAC C; R: AGG ATT ACC
CGA GAT CAC CTG C; [32]) and Def1 (F: TGC GCT GCT AAC TGT CTC AG; R: AAT GGC ACT TAA
CCG AAA CG; [33]) from the heads of eight individuals per colony for each treatment and time period
using only the 14 day old bees. Briefly, total RNA was extracted using the Maxwell® system with the
LEV simplyRNA tissue kit (Promega). cDNA synthesis was performed using the QuantiTect Reverse
Transcription Kit (Qiagen Inc.) following the manufacturer’s protocols. qPCR reactions were conducted
using a CFX96™ Real-Time PCR (BioRad, Inc.). Amplification was performed in 10 µl volumes using
PowerUP SYBR Green Master Mix (Applied Biosystems) under the following thermal protocol: 95°C
hold for 20 s, 40 cycles of 95°C for 1 s, 60°C for 5 s followed by a melt-curve dissociation analysis. All
reactions included three technical replicates and qPCR data were expressed as the threshold cycle (Ct)
values normalized to expression of β-actin (F: TGC CAA CAC TGT CCT TTC TG; R: AGA ATT GAC
CCA CCA ATC CA; [34]) and calculated using the 2−Ct method following standard protocols [35].
The average for the colony at T0 (pre-infection) was used as the calibrator, and so normalized expression
values were made relative to this.
2.4. Statistical analysis
We estimated the average GOX enzymatic activity of the three technical replicates for enzymatic activity
(GOX) and the expression data (GOX and Def1). Samples that showed standard deviations greater than 2
among replicates were inspected for outliers. We removed single values deviated more than ±2 from the
other two replicates, or removed the whole sample if the two remaining replicates after outlier removal
still deviated by more than 2. Generalized mixed linear models were built using ‘treatment’ and ‘time’
as fixed effects, and the variable ‘colony’ was included as a random effect. For the enzymatic GOX data,
‘plate’ was also included as a random effect to account for any variability from the specific groups of
samples that was analysed in the same plate (31 samples and 1 negative control). Models for 7 and 14
day old bees were analysed separately. Linear models were analysed using the maximum-likelihood
approach of the lme function of the R package nlme [36].
3. Results
The number of larval cells with overt AFB symptoms increased over time after initial infections in all




Table 2. Mixed linear models testing the effect of AFB treatment on levels of GOX enzymatic production for 7 and 14 day old bees,
and transcript expression of GOX and Def-1 in 14 day old bees. (P-values less than 0.05 (in italics) indicate a significant effect.)
numDF denDF F-value P-value
GOX production—7 day old bees
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time 2 242 0.3979 0.6722
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
treatment 1 6 0.0103 0.9226
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time× treatment 2 242 0.295 0.7451
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GOX production—14 day old bees
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time 2 181 0.0919 0.9122
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
treatment 1 5 0.116 0.7519
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time× treatment 2 181 0.0164 0.9837
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
GOX expression
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
treatment 1 4 0.0072 0.9363
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time 2 116 8.6718 0.0003
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time× treatment 2 116 0.7687 0.4660
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Def1 expression
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
treatment 1 4 0.5901 0.4852
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time 2 116 6.8964 0.0015
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
time× treatment 2 116 1.3848 0.2545
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
detect a significant change in GOX activity between treatment and control colonies in 7 day (F1,6= 0.01,
p= 0.923) or 14 day old (F1,5= 0.116, p= 0.752) bees (table 2; figure 2). For gene expression of GOX,
there was no significant interaction between time and treatment (F2,116= 1.385, p= 0.255) and no effect
of AFB treatment (F1,4= 0.007, p= 0.936) (figure 2). However, there was an overall significant effect of
time (F2,118= 8.672, p= 0.003), with bees at T1 having lower GOX expression than bees at T0 or T2. A
similar finding was determined for Def1, with no significant effect for the interaction between time and
treatment (F2,116= 1.385, p= 0.255) or AFB treatment (F1,4= 0.59, p= 0.485). There was an effect of time
(F2,116= 6.896, p= 0.015), with significantly lower Def1 expression levels at T1 when compared with T0,
and T2.
4. Discussion
GOX enzymatic activity and expression levels were not induced in 7 day old or 14 day old bees after
honeybee colonies were challenged with a bacterial pathogen (AFB). Even though all infected colonies
showed symptoms of disease, enzymatic production of GOX and transcription of GOX and Def1 were
unaffected at the colony level. The fact that Def1 was not induced by exposure to AFB is not entirely
unexpected. Even though Def1 is an antimicrobial peptide that responds to bacterial infection [37], AFB
does not infect adults and only infects the larval stage. However, expression of antimicrobial peptides is
typically used as a measure of inducible immunity for studies examining investment in mechanisms of
individual immunity [10,11], even though they do show constitutive and genetically based expression
patterns [38]. Our results therefore highlight the importance of considering whether these compounds
can be induced in a social context. While there was no overall increase in expression after infection, we
found a significant reduction in GOX and Def1 expression levels during T1 for both control and treatment
colonies. We are uncertain about the causes of this result and it is probably owing to various, wider
environmental factors that were not measured in this experiment.
Our results indicate that even though GOX and Def1 are secreted into larval food for antiseptic
properties, they remain constitutively expressed and are not increased owing to pathogen pressure.
These findings are supported by previous work in GOX [24], and other types of constitutive immune
defences such as metapleural [39] and venom gland secretions [21]. On the contrary to what we found
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Figure 2. Levels of GOX enzymatic activity (a,b), and relative transcript abundances for GOX (c) and Def1 (d) represented in boxplots.
Each box represents the median (middle horizontal line), first and third quartile (upper and bottom horizontal lines, respectively), and
the vertical lines extend to themaximumandminimums of the data, with the circles outside of these boundaries indicating outliers. Grey
and white boxplots depict control and AFB treatment colonies, respectively.
resins, can be induced after colony-level pathogen challenges [18,19]. Our data also suggest colony-level
differences in GOX production, indicating that the genetic background of colonies may be a significant
factor influencing the level of investment in expression of these antimicrobial compounds. In fact, one
earlier study documented that colonies bred for resistance to AFB may have exhibited positive selection
for constitutively increasing the level of antimicrobial compounds in the brood food [40], without
knowing the responsible compounds. In this scenario, one mechanism of AFB resistance was found to
be owing to an increase in antimicrobial activity of brood food, and thus those colonies displayed an
increase in this particular mechanism as a constitutive social immune defence.
GOX activity and Def1 expression have often been analysed as parameters of social immunity, as it has
been hypothesized to prevent diseases through colony-food sterilization [41]. While the antiseptic role of
these compounds is clear, it is unknown how colonies invest in these as mechanisms of social immunity.
It is possible that the production of constitutive defences, such as GOX and Def1, may be maintained
to prevent initial pathogen infection in social insects [40]. GOX has been detected in larval food of
solitary bees [42], on grasshopper cuticles [43] and in other herbivorous insects [44], which suggests that
the use of this enzyme as an antimicrobial secretion is an ancestral trait in non-social insects. As such
GOX production in these different species fits the broader definitions of social immunity as proposed
by Cotter & Kilner [2], and clarified by Meunier [3], whereby parental care and care of siblings can be
described as an aspect of social immunity in social, communal and even solitary species.
Taken together, our results and the evidence of widespread use of GOX and Def1 suggest that some of
the antimicrobial compounds produced by social insects can be co-opted to function as mechanisms of
social immunity. Because social insects have stronger selective pressure of pathogen spread, they rely on




defences, constitutive or inducible mechanisms that benefit individuals and groups (figure 1; [4,6]). In
addition, recent evidence in wood ants suggests that some species can mix antimicrobial compounds
from self-produced and external sources, which increases their antimicrobial potential [45]. This
highlights the need and ability of social insects to rely on both constitutive and inducible immune
responses. The combination of the wide range of defences may therefore compensate for reduced
physiological immune responses in social insects [46]. Understanding how colonies invest in defences
across this continuum is key to gaining insight into the evolution of these defences and how pathogen
pressure influences this investment.
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